Kailera Therapeutics, Inc. (KLRA) Insider Trading

Name: Kailera Therapeutics, Inc. (KLRA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 9, 2026): Nicholson Nur (Chief Technology Officer): Grant/Award of 220,000 shares.

Get alerted when insiders trade KLRA

Email address

Loading company data...

Beta

Loading company details...

Beta